Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosis.


Journal

Journal of autoimmunity
ISSN: 1095-9157
Titre abrégé: J Autoimmun
Pays: England
ID NLM: 8812164

Informations de publication

Date de publication:
08 2019
Historique:
received: 25 01 2019
revised: 09 04 2019
accepted: 12 04 2019
pubmed: 6 5 2019
medline: 23 7 2020
entrez: 6 5 2019
Statut: ppublish

Résumé

Autoreactive CD4

Identifiants

pubmed: 31054941
pii: S0896-8411(19)30036-8
doi: 10.1016/j.jaut.2019.04.013
pii:
doi:

Substances chimiques

Autoantibodies 0
Autoantigens 0
HLA-DR Antigens 0
IFNG protein, human 0
IL17A protein, human 0
Interleukin-17 0
Interleukins 0
Myelin-Oligodendrocyte Glycoprotein 0
Natalizumab 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-49

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Mattias Bronge (M)

Therapeutic Immune Design, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine L8:02, 171 76, Stockholm, Sweden. Electronic address: Mattias.Bronge@ki.se.

Sabrina Ruhrmann (S)

Therapeutic Immune Design, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine L8:02, 171 76, Stockholm, Sweden. Electronic address: Sabrina.Ruhrmann@ki.se.

Claudia Carvalho-Queiroz (C)

Therapeutic Immune Design, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine L8:02, 171 76, Stockholm, Sweden. Electronic address: Claudia.Queiroz@ki.se.

Ola B Nilsson (OB)

Therapeutic Immune Design, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine L8:02, 171 76, Stockholm, Sweden. Electronic address: Ola.Nilsson.1@ki.se.

Andreas Kaiser (A)

Therapeutic Immune Design, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine L8:02, 171 76, Stockholm, Sweden. Electronic address: Andreas.Kaiser.1@ki.se.

Erik Holmgren (E)

Therapeutic Immune Design, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine L8:02, 171 76, Stockholm, Sweden. Electronic address: Erik.Holmgren@ki.se.

Caterina Macrini (C)

Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 821 52, Planegg-Martinsried, Germany. Electronic address: Caterina.Macrini@med.uni-muenchen.de.

Stephan Winklmeier (S)

Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 821 52, Planegg-Martinsried, Germany. Electronic address: Stephan.Winklmeier@med.uni-muenchen.de.

Edgar Meinl (E)

Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 821 52, Planegg-Martinsried, Germany. Electronic address: Edgar.Meinl@med.uni-muenchen.de.

Lou Brundin (L)

Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine L8:04, 171 76, Stockholm, Sweden. Electronic address: Lou.Brundin@ki.se.

Mohsen Khademi (M)

Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine L8:04, 171 76, Stockholm, Sweden. Electronic address: Mohsen.Khademi@ki.se.

Tomas Olsson (T)

Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine L8:04, 171 76, Stockholm, Sweden. Electronic address: Tomas.Olsson@ki.se.

Guro Gafvelin (G)

Therapeutic Immune Design, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine L8:02, 171 76, Stockholm, Sweden. Electronic address: Guro.Gafvelin@ki.se.

Hans Grönlund (H)

Therapeutic Immune Design, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine L8:02, 171 76, Stockholm, Sweden. Electronic address: Hans.Gronlund@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH